Substituted alkylamine derivatives and methods of use

Details Substituted alkylamine derivatives and methods of use Substituted alkylamine derivatives and methods of use

2005-04-12

2005-04-12

Raymond, Richard L. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S300000, C514S314000, C514S333000, C514S336000, C514S337000, C544S333000, C546S113000, C546S175000, C546S256000, C546S262000, C546S271700, C546S282100, C546S282700

Reexamination Certificate

active

06878714

ABSTRACT:
Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

REFERENCES:
patent: 3226394 (1965-12-01), Schipper et al.
patent: 5532358 (1996-07-01), Kelly
patent: 6140351 (2000-10-01), Arnaiz et al.
patent: 6506747 (2003-01-01), Betageri et al.
patent: 6624174 (2003-09-01), Manley et al.
patent: 0 947 500 (1999-10-01), None
patent: 1219609 (2002-07-01), None
patent: 2 168 227 (1973-08-01), None
patent: 2000 256358 (2000-09-01), None
patent: WO 9641795 (1996-12-01), None
patent: WO 9824771 (1998-06-01), None
patent: WO 9845268 (1998-10-01), None
patent: WO 9932477 (1999-07-01), None
patent: WO 9962885 (1999-12-01), None
patent: WO 0002851 (2000-01-01), None
patent: WO 0027819 (2000-05-01), None
patent: WO 0027820 (2000-05-01), None
patent: WO 0039111 (2000-07-01), None
patent: WO 0039117 (2000-07-01), None
patent: WO 0047212 (2000-08-01), None
patent: WO 0129009 (2001-04-01), None
patent: WO 0130745 (2001-05-01), None
patent: WO 0155114 (2001-08-01), None
patent: WO 0155115 (2001-08-01), None
patent: WO 0181311 (2001-11-01), None
patent: WO 0185671 (2001-11-01), None
patent: WO 0185691 (2001-11-01), None
patent: WO 0185715 (2001-11-01), None
patent: WO 02055501 (2002-07-01), None
patent: WO 02066470 (2002-08-01), None
Betageri et al., Chemical Abstracts, vol. 132:22963, 1999.*
Singh, et al., “Substituted Imidazolines and Their CNS Activity” Ind.J.Het.Chem. 2: 129-132 (1992).
Seto, et al., “Molecular Self-Assembly through Hydrogen Bonding: Supramolecular Aggregates Based on the Cyanuric Acid•Melamine Lattice” J.Am.Chem.Soc. 115: 905-916 (1993).
Bold et al., “New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven Angiogenesis”, J. Med. Chem . . . , 43:2310-2323 (2000).
Breier et al., “The role of vascular endothelial growth factor in blood vessel formation”, Trends in Cell Biology, 6:454-456 (1996).
Connell et al., “Patent focus on cancer chemotherapeutics. II Angiogenesis agents: Apr. 2000—Sep. 2000”, Exp. Opin. Ther. Patents, 11:77-114 (2001).
Hennequin et al., “Design and Structure-Activity Relationship of a New Class of Potent VEGF Receptor Tyrosine Kinase Inhibitor”, J. Med. Chem., 42:5369-5389 (1999).
Konshin et al., Synthesis and antimicrobial activity of arylamides of N-(4-pyridyl)anthranilic acid, Chem. Abstr., 97:109837 (1981).
Sun et al., “Design, Synthesis and Evaluations of substituted 3-[(3- or 4-Carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as Inhibitors of VEGF, FGF, PDGF Receptor Tyrosine Kinases”, J. Med. Chem., 42:5120-5130 (1999).

Affiliated with

Also associated with

Rating

Substituted alkylamine derivatives and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted alkylamine derivatives and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted alkylamine derivatives and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3432718